Prostate cancer – Advantages and disadvantages of MR-guided RT-Reference-Cited by-同舟云学术

Prostate cancer – Advantages and disadvantages of MR-guided RT

Published:2019-09 Issue: Volume:18 Page:68-73
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Murray Julia,Tree Alison C.

Funder

National Institute for Health Research

Biomedical Research Centre

Royal Marsden NHS Foundation Trust

Institute of Cancer Research

Department of Health

Rosetrees Trust

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference30 articles.

1. EU. Epidemiology of prostate cancer in Europe [Internet]. EU science hub. Available from: https://ec.europa.eu/jrc/en/publication/epidemiology-prostate-cancer-europe.

2. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol. [Internet],2007

3. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;Lancet Oncol.,2016

4. Trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer;Catton;Int. J. Clin. Oncol.,2017

5. Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397;Gulliford;Int J Radiat Oncol Biol Phys [Internet],2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive analysis of the challenges and potential side effects of radiation therapy for palliative cancer treatment;Médecine Palliative;2024-03

2. Adaptive ultra‐hypofractionated whole‐pelvic radiotherapy in high‐risk and very high‐risk prostate cancer on 1.5‐Tesla MR‐Linac: Estimated delivered dose and early toxicity results;Chronic Diseases and Translational Medicine;2024-01-21

3. MRI-Guided Adaptive Radiation Therapy;Seminars in Radiation Oncology;2024-01

4. Impact of 1.5 T Magnetic Field on Treatment Plan Quality in MR-Guided Radiotherapy: Typical Phantom Test Cases;Technology in Cancer Research & Treatment;2024-01

5. Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy;Frontiers in Oncology;2023-12-20